{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:27:49Z","timestamp":1769099269135,"version":"3.49.0"},"reference-count":550,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.brainres.2019.146398","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T20:19:53Z","timestamp":1566332393000},"page":"146398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults"],"prefix":"10.1016","volume":"1723","author":[{"given":"Stephanie M.","family":"Matt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Gaskill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011175","article-title":"Diabetes mellitus among HIV-infected individuals in follow-up care at University of Gondar Hospital Northwest Ethiopia","volume":"6","author":"Abebe","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.brainres.2019.146398_b0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.09.113","article-title":"Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates","volume":"1306","author":"Agrawal","year":"2010","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s002130050791","article-title":"Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat","volume":"140","author":"Ainsworth","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146398_b0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ibror.2019.04.002","article-title":"Combination antiretroviral therapy (cART)-induced hippocampal disorders: highlights on therapeutic potential of Naringenin and Quercetin","volume":"6","author":"Akang","year":"2019","journal-title":"IBRO Rep."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2005.10.095","article-title":"HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity","volume":"395","author":"Aksenova","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hup.813","article-title":"Major depression-related immunological changes and combination antiretroviral therapy in HIV-seropositive patients","volume":"22","author":"Alciati","year":"2007","journal-title":"Hum. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b0035","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1007\/s12035-015-9408-7","article-title":"Stress-Induced depressive behaviors require a functional NLRP3 inflammasome","volume":"53","author":"Alcocer-Gomez","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"4S3","key":"10.1016\/j.brainres.2019.146398_b0040","doi-asserted-by":"crossref","first-page":"19711","DOI":"10.7448\/IAS.17.4.19711","article-title":"Overall and cause-specific mortality in HIV-positive subjects compared to the general population","volume":"17","author":"Alejos","year":"2014","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11481-018-09827-w","article-title":"Letter to editor","volume":"14","author":"Al-Harthi","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2325957414536228","article-title":"Gender differences in severity and correlates of depression symptoms in people living with HIV in Ontario, Canada","volume":"15","author":"Aljassem","year":"2016","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/mi.2015.58","article-title":"The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients","volume":"9","author":"Allers","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/cid\/ciu869","article-title":"Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults","volume":"60","author":"Althoff","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","author":"American Geriatrics Society","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"issue":"23","key":"10.1016\/j.brainres.2019.146398_b0070","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003738","article-title":"Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection","volume":"95","author":"Amu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0361-9230(94)90064-7","article-title":"Effect of morphine applied by intrapallidal microdialysis on the release of dopamine in the nucleus accumbens","volume":"34","author":"Anagnostakis","year":"1994","journal-title":"Brain Res. Bull."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.2042-7158.1967.tb09604.x","article-title":"Evidence for dopamine receptor stimulation by apomorphine","volume":"19","author":"And\u00e9n","year":"1967","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0085","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1046\/j.1471-4159.1996.67051931.x","article-title":"Effects of (-)-sulpiride on dopamine release in striatum of developing rats: degree of depolarization influences responsiveness","volume":"67","author":"Andersen","year":"1996","journal-title":"J. Neurochem."},{"issue":"Pt B","key":"10.1016\/j.brainres.2019.146398_b0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nbd.2015.10.018","article-title":"Reward, attention, and HIV-related risk in HIV+ individuals","volume":"92","author":"Anderson","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0095","first-page":"31","article-title":"Depression and adjustment disorder in patients with HIV disease","volume":"10","author":"Angelino","year":"2002","journal-title":"Top. HIV Med."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153493","article-title":"Characteristics of resting-state functional connectivity in HIV-associated neurocognitive disorder","volume":"11","author":"Ann","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnen\/64.6.529","article-title":"Influence of HAART on HIV-related CNS disease and neuroinflammation","volume":"64","author":"Anthony","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)01025-X","article-title":"Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism","volume":"332","author":"Antkiewicz-Michaluk","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/QAI.0b013e31815acab8","article-title":"Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine\/lamivudine and efavirenz in treatment-naive patients: 144-week analysis","volume":"47","author":"Arribas","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/pcn.12097","article-title":"HIV infection and depression","volume":"68","author":"Arseniou","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1525-1497.2003.20938.x","article-title":"Underdiagnosis of depression in HIV: who are we missing?","volume":"18","author":"Asch","year":"2003","journal-title":"J. Gen. Intern. Med."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0135","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-014-0024-z","article-title":"Single-tablet regimens in HIV therapy","volume":"3","author":"Astuti","year":"2014","journal-title":"Infect. Dis. Therapy"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0145","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01186-17","article-title":"Brain macrophages in simian immunodeficiency virus-infected, antiretroviral-suppressed macaques: a functional latent reservoir","volume":"8","author":"Avalos","year":"2017","journal-title":"MBio"},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b0150","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1176\/ajp.152.7.987","article-title":"Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia","volume":"152","author":"Aylward","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1471-4159.1979.tb11048.x","article-title":"Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine","volume":"32","author":"Bacopoulos","year":"1979","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1037\/0278-6133.26.1.40","article-title":"Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status","volume":"26","author":"Barclay","year":"2007","journal-title":"Health Psychol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199861","article-title":"Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: implications to HIV infection","volume":"13","author":"Basova","year":"2018","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0170","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/jac\/dkv036","article-title":"Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity","volume":"70","author":"Bastard","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pbb.2008.02.018","article-title":"Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain","volume":"90","author":"Baumann","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11682-011-9113-8","article-title":"Subcortical brain atrophy persists even in HAART-regulated HIV disease","volume":"5","author":"Becker","year":"2011","journal-title":"Brain Imaging Behav."},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b0185","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0006-8993(95)01166-8","article-title":"HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures","volume":"705","author":"Bennett","year":"1995","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0195","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PSY.0b013e3181f883ce","article-title":"Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication","volume":"72","author":"Benton","year":"2010","journal-title":"Psychosom. Med."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-199401000-00010","article-title":"Cerebrospinal fluid dopamine in HIV-1 infection","volume":"8","author":"Berger","year":"1994","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/026988110001400304","article-title":"HIV dementia: the role of the basal ganglia and dopaminergic systems","volume":"14","author":"Berger","year":"2000","journal-title":"J. Psychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.brainres.2019.146398_b0210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000150539","article-title":"HIV dementia and the basal ganglia","volume":"40","author":"Berger","year":"1997","journal-title":"Intervirology"},{"key":"10.1016\/j.brainres.2019.146398_b0215","article-title":"Systemic inflammation is associated with depressive symptoms differentially by sex and race: a longitudinal study of urban adults","author":"Beydoun","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b0220","first-page":"p. WC01-4","article-title":"Prevalence of depression in people living with HIV\/AIDS undergoing ART and factors associated with it","volume":"8","author":"Bhatia","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0225","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11904-008-0023-3","article-title":"The aging of the HIV epidemic","volume":"5","author":"Bhavan","year":"2008","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b0230","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.58.8.721","article-title":"Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States","volume":"58","author":"Bing","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00346479","article-title":"Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene","volume":"224","author":"Bjerkenstedt","year":"1970","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0240","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1089\/aid.2011.0377","article-title":"Definition of advanced age in HIV infection: looking for an age cut-off","volume":"28","author":"Blanco","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1189\/jlb.3HI0216-068RR","article-title":"Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI","volume":"101","author":"Bone","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0250","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neulet.2010.12.010","article-title":"Ethanol-induced increases in extracellular dopamine are blunted in brain-derived neurotrophic factor heterozygous mice","volume":"489","author":"Bosse","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0255","first-page":"374","article-title":"HIV associated neurocognitive disorders","volume":"39","author":"Braganca","year":"2011","journal-title":"Actas Esp. Psiquiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02261001","article-title":"Low and high dose bromocriptine have different effects on striatal dopamine release: an in vivo study","volume":"6","author":"Brannan","year":"1993","journal-title":"J. Neural Transm. Park Dis. Dement. Sect."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1176\/ajp.153.2.231","article-title":"A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients","volume":"153","author":"Breitbart","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0270","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","article-title":"Dopamine in motivational control: rewarding, aversive, and alerting","volume":"68","author":"Bromberg-Martin","year":"2010","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b0275","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2105\/AJPH.2012.300844","article-title":"HIV infection and older Americans: the public health perspective","volume":"102","author":"Brooks","year":"2012","journal-title":"Am. J. Public Health"},{"issue":"16","key":"10.1016\/j.brainres.2019.146398_b0280","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/0024-3205(78)90471-X","article-title":"Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity","volume":"23","author":"Bunney","year":"1978","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0285","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/QAD.0b013e32836010bd","article-title":"Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection","volume":"27","author":"Burdo","year":"2013","journal-title":"Aids"},{"key":"10.1016\/j.brainres.2019.146398_b0290","first-page":"251","article-title":"Management of HIV\/AIDS in older patients-drug\/drug interactions and adherence to antiretroviral therapy","volume":"7","author":"Burgess","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"issue":"23","key":"10.1016\/j.brainres.2019.146398_b0295","doi-asserted-by":"crossref","first-page":"12233","DOI":"10.1128\/JVI.76.23.12233-12241.2002","article-title":"Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains","volume":"76","author":"Burudi","year":"2002","journal-title":"J. Virol."},{"issue":"44","key":"10.1016\/j.brainres.2019.146398_b0300","doi-asserted-by":"crossref","first-page":"38703","DOI":"10.1074\/jbc.M111.275370","article-title":"Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome","volume":"286","author":"Busillo","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11481-016-9652-2","article-title":"Neuropsychological, neurovirological and neuroimmune aspects of abnormal GABAergic transmission in HIV infection","volume":"11","author":"Buzhdygan","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1345\/aph.1E248","article-title":"Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV","volume":"39","author":"Caballero","year":"2005","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0315","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.2105\/AJPH.2012.301161","article-title":"Growing older with HIV\/AIDS: new public health challenges","volume":"103","author":"Cahill","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0320","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10461-008-9435-8","article-title":"Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil","volume":"14","author":"Campos","year":"2010","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0034-1372340","article-title":"HIV and aging: effects on the central nervous system","volume":"34","author":"Ca\u00f1izares","year":"2014","journal-title":"Semin. Neurol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0330","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0335","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jad.2011.06.021","article-title":"Functional connectivity of emotional processing in depression","volume":"134","author":"Carballedo","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b0340","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1128\/JVI.02234-06","article-title":"Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway","volume":"81","author":"Carroll-Anzinger","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0345","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JVI.80.1.541-544.2006","article-title":"Gamma interferon primes productive human immunodeficiency virus infection in astrocytes","volume":"80","author":"Carroll-Anzinger","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0350","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(91)90666-E","article-title":"Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo","volume":"200","author":"Carter","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0355","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v64n0411","article-title":"An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder","volume":"64","author":"Carvalhal","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b0360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0006-8993(03)03122-6","article-title":"HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat","volume":"984","author":"Cass","year":"2003","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b0365","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/QAD.0000000000000303","article-title":"Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment","volume":"28","author":"Cassol","year":"2014","journal-title":"AIDS (London, England)"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0370","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/13803390590935444","article-title":"Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance","volume":"28","author":"Castellon","year":"2006","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.brainres.2019.146398_b0375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2017.02.009","article-title":"HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum","volume":"799","author":"Cavalcante","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(90)94805-8","article-title":"The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test","volume":"178","author":"Cervo","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0385","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0306-3623(88)90153-X","article-title":"Domperidone","volume":"19","author":"Champion","year":"1988","journal-title":"General Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0390","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.neurobiolaging.2012.10.012","article-title":"Lower cognitive reserve in the aging human immunodeficiency virus-infected brain","volume":"34","author":"Chang","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biopsych.2013.09.020","article-title":"Amygdala-ventral pallidum pathway decreases dopamine activity after chronic mild stress in rats","volume":"76","author":"Chang","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"7433","key":"10.1016\/j.brainres.2019.146398_b0400","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11713","article-title":"Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons","volume":"493","author":"Chaudhury","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(93)90298-2","article-title":"Ventral tegmental microinjection of \u03949-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient","volume":"621","author":"Chen","year":"1993","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b0410","article-title":"Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0415","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/npp.2012.140","article-title":"Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain","volume":"38","author":"Chenu","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2019.146398_b0420","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00002030-200418001-00005","article-title":"Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings","volume":"18","author":"Cherner","year":"2004","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0425","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/npp.2008.114","article-title":"Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain","volume":"34","author":"Chernoloz","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0430","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00042560-199601010-00005","article-title":"Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group","volume":"11","author":"Chiesi","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"issue":"13","key":"10.1016\/j.brainres.2019.146398_b0435","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2019.146398_b0440","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0306-4530(97)00015-2","article-title":"Serum cortisol and DHEA concentrations during HIV infection","volume":"22","author":"Christeff","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2019.146398_b0445","first-page":"431","article-title":"A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase","volume":"7","author":"Christmas","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0450","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","article-title":"Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia","volume":"66","author":"Churchill","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2019.146398_b0455","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000001489","article-title":"Progressive brain atrophy despite persistent viral suppression in HIV over age 60","author":"Clifford","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0460","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0000000000001489","article-title":"Progressive brain atrophy despite persistent viral suppression in HIV patients older than 60 years","volume":"76","author":"Clifford","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.brainres.2019.146398_b0465","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2016.01.011","article-title":"The neurobiology of HIV and its impact on cognitive reserve: a review of cognitive interventions for an aging population","volume":"92","author":"Cody","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0470","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S135561770707066X","article-title":"Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals","volume":"13","author":"Cole","year":"2007","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"14","key":"10.1016\/j.brainres.2019.146398_b0475","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1212\/WNL.0000000000003790","article-title":"Increased brain-predicted aging in treated HIV disease","volume":"88","author":"Cole","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b0480","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0002-9343(02)01259-7","article-title":"Neuropsychiatric reaction induced by abacavir","volume":"113","author":"Colebunders","year":"2002","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0485","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00002030-200301030-00018","article-title":"Serum cortisol in HIV-infected patients with and without highly active antiretroviral therapy","volume":"17","author":"Collazos","year":"2003","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0490","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1176\/appi.psy.44.2.120","article-title":"A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients","volume":"44","author":"Currier","year":"2003","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617707070026","article-title":"Incident major depression does not affect neuropsychological functioning in HIV-infected men","volume":"13","author":"Cysique","year":"2007","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0500","first-page":"85","article-title":"Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs","volume":"101","author":"Czub","year":"2001","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0505","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00401-003-0801-3","article-title":"Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs","volume":"107","author":"Czub","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0510","first-page":"339","article-title":"Effect of venlafaxine and nicotine on the level of neurotransmitters and their metabolites in rat brains","volume":"61","author":"Czubak","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0515","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-3565(25)23665-5","article-title":"Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A","volume":"248","author":"Da Prada","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0520","first-page":"185","article-title":"Associated factors of suicidal thoughts in HIV-positive individuals","volume":"10","author":"Dabaghzadeh","year":"2015","journal-title":"Iran. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0525","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1755-5949.2009.00125.x","article-title":"The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats","volume":"16","author":"Dagyte","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0530","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5603\/MH.2014.0004","article-title":"Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting","volume":"65","author":"Dahl","year":"2014","journal-title":"Int. Marit. Health"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0535","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b0540","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2016.04.028","article-title":"Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz","volume":"110","author":"Dalwadi","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0545","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0550","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","article-title":"Early viral brain invasion in iatrogenic human immunodeficiency virus infection","volume":"42","author":"Davis","year":"1992","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0555","first-page":"29","article-title":"A quantitative MRI study of the Basal Ganglia in depression in HIV seropositive men","volume":"1","author":"Davison","year":"1997","journal-title":"J. NeuroAIDS"},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b0560","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/00004647-200110000-00003","article-title":"Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition","volume":"21","author":"de La Fuente-Fernandez","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0565","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12977-018-0458-6","article-title":"Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection","volume":"15","author":"de Paula","year":"2018","journal-title":"Retrovirology"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0570","first-page":"118","article-title":"Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy","volume":"17","author":"Deeks","year":"2009","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.brainres.2019.146398_b0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu. Rev. Med."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b0580","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s10461-015-1082-2","article-title":"Depression and oral FTC\/TDF pre-exposure prophylaxis (PrEP) among men and transgender women who have sex with men (MSM\/TGW)","volume":"20","author":"Defechereux","year":"2016","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0585","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02814940","article-title":"Effect of piribedil, a D-2 dopaminergic agonist, on dopamine, amino acids, and free radicals in gerbil brain after cerebral ischemia","volume":"26","author":"Delbarre","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"issue":"Suppl. 6","key":"10.1016\/j.brainres.2019.146398_b0590","first-page":"7","article-title":"Depression: the case for a monoamine deficiency","volume":"61","author":"Delgado","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146398_b0595","series-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV","author":"Department of Health and Human Services","year":"2017"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0600","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00213-011-2447-5","article-title":"Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex","volume":"219","author":"Devoto","year":"2012","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2019.146398_b0605","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(00)00122-9","article-title":"Role of dopamine in the behavioural actions of nicotine related to addiction","volume":"393","author":"Di Chiara","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130050465","article-title":"Blunting of reactivity of dopamine transmission to palatable food: a biochemical marker of anhedonia in the CMS model?","volume":"134","author":"Di Chiara","year":"1997","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0615","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0361-9230(98)00054-9","article-title":"Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area","volume":"46","author":"Di Mascio","year":"1998","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0620","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00002826-200007000-00004","article-title":"Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients","volume":"23","author":"di Rocco","year":"2000","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0625","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jagp.2019.01.181","article-title":"INFLAMMATION, dopaminergic decline, and psychomotor slowing as pathologic routes to late life depression","volume":"27","author":"Diniz","year":"2019","journal-title":"Am. J. Geriatric Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0630","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10461-018-2282-3","article-title":"The depression treatment cascade: disparities by alcohol use, drug use, and panic symptoms among patients in routine HIV care in the United States","volume":"23","author":"DiPrete","year":"2019","journal-title":"AIDS Behav."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092842","article-title":"Excess burden of depression among HIV-infected persons receiving medical care in the united states: data from the medical monitoring project and the behavioral risk factor surveillance system","volume":"9","author":"Do","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2019.146398_b0640","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-200401001-00006","article-title":"HIV, psychosis and aging: past, present and future","volume":"18","author":"Dolder","year":"2004","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0645","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0650","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2004.09.013","article-title":"Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment","volume":"48","author":"Dremencov","year":"2005","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0655","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1139\/jpn.0930","article-title":"Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area","volume":"34","author":"Dremencov","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b0660","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)01020-9","article-title":"Neuroimaging studies of mood disorders","volume":"48","author":"Drevets","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0665","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-2999(90)90366-E","article-title":"Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia","volume":"187","author":"Drew","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b0670","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1124\/dmd.115.064824","article-title":"Potent and selective inhibition of plasma membrane monoamine transporter by HIV protease inhibitors","volume":"43","author":"Duan","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0675","first-page":"327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0680","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.1989.tb09192.x","article-title":"Dopamine release in rat striatum: physiological coupling to tyrosine supply","volume":"52","author":"During","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2019.146398_b0685","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08964289.2013.866540","article-title":"Substance abuse treatment in persons with HIV\/AIDS: challenges in managing triple diagnosis","volume":"40","author":"Durvasula","year":"2014","journal-title":"Behav. Med. (Washington, D.C.)"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0690","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2011.150318","article-title":"The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses","volume":"71","author":"Ebbinghaus","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b0695","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","article-title":"The next therapeutic challenge in HIV: polypharmacy","volume":"30","author":"Edelman","year":"2013","journal-title":"Drugs Aging"},{"issue":"8554","key":"10.1016\/j.brainres.2019.146398_b0700","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(87)90937-8","article-title":"Severe parkinsonism in two AIDS patients taking prochlorperazine","volume":"2","author":"Edelstein","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0705","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/590150","article-title":"Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions","volume":"47","author":"Effros","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0710","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1755-5949.2010.00146.x","article-title":"Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder","volume":"16","author":"El Mansari","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0715","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00004714-200004000-00023","article-title":"Mirtazapine for depression in patients with human immunodeficiency virus","volume":"20","author":"Elliott","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0720","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archneurol.2010.76","article-title":"Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study","volume":"67","author":"Ellis","year":"2010","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0725","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0006-8993(91)90109-9","article-title":"Reserpine-insensitive dopamine release in the substantia nigra?","volume":"557","author":"Elverfors","year":"1991","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0730","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/geront\/46.6.781","article-title":"\u201cYou're awfully old to have this disease\u201d: experiences of stigma and ageism in adults 50 years and older living with HIV\/AIDS","volume":"46","author":"Emlet","year":"2006","journal-title":"Gerontologist"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b0735","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2003.11.011","article-title":"Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen","volume":"148","author":"Engler","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0740","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.21594","article-title":"Declined neural efficiency in cognitively stable human immunodeficiency virus patients","volume":"65","author":"Ernst","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2019.146398_b0745","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2147\/CIA.S176329","article-title":"Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study","volume":"13","author":"Ersoy","year":"2018","journal-title":"Clin. Interv. Aging"},{"issue":"26","key":"10.1016\/j.brainres.2019.146398_b0750","doi-asserted-by":"crossref","first-page":"9456","DOI":"10.1523\/JNEUROSCI.1460-11.2011","article-title":"Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism","volume":"31","author":"Eugenin","year":"2011","journal-title":"J. Neurosci."},{"issue":"47","key":"10.1016\/j.brainres.2019.146398_b0755","doi-asserted-by":"crossref","first-page":"12844","DOI":"10.1523\/JNEUROSCI.4154-07.2007","article-title":"Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes","volume":"27","author":"Eugenin","year":"2007","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0760","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/jnc.12443","article-title":"Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism","volume":"127","author":"Eugenin","year":"2013","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0765","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1310\/hct0806-437","article-title":"Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090","volume":"8","author":"Evans","year":"2007","journal-title":"HIV Clin. Trials"},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b0770","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11908-017-0606-5","article-title":"Neurological complications of HIV infection","volume":"19","author":"Farhadian","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100273","article-title":"Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa","volume":"9","author":"Fatti","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0780","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.ajp.2015.15060788","article-title":"Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression","volume":"173","author":"Fawcett","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146398_b0785","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b0790","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1017\/S1041610212000944","article-title":"Frequency and risk factors for HIV-associated neurocognitive disorder and depression in older individuals with HIV in northeastern Brazil","volume":"24","author":"Fernandes Filho","year":"2012","journal-title":"Int. Psychogeriatr."},{"issue":"6 Suppl 1","key":"10.1016\/j.brainres.2019.146398_b0795","doi-asserted-by":"crossref","first-page":"1539S","DOI":"10.1093\/jn\/137.6.1539S","article-title":"Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain","volume":"137","author":"Fernstrom","year":"2007","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0800","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-8343(96)00172-7","article-title":"Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS: improvements in affective and somatic symptoms","volume":"19","author":"Ferrando","year":"1997","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0805","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(96)00182-3","article-title":"The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism","volume":"306","author":"Ferraro","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0810","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QAI.0000000000001269","article-title":"Psychiatric symptoms in patients receiving dolutegravir","volume":"74","author":"Fettiplace","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.brainres.2019.146398_b0815","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-7091-6499-0_28","article-title":"Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey","volume":"52","author":"Finberg","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.brainres.2019.146398_b0820","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nn1103","article-title":"Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission","volume":"6","author":"Floresco","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"18","key":"10.1016\/j.brainres.2019.146398_b0825","first-page":"2449","article-title":"More on abacavir-induced neuropsychiatric reactions","volume":"18","author":"Foster","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.brainres.2019.146398_b0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech. Ageing Dev."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2019.146398_b0835","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0840","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1742-2094-8-88","article-title":"HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner","volume":"8","author":"Fu","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b0845","first-page":"339","article-title":"Depression in HIV-infected patients: allopathic, complementary, and alternative treatments","volume":"57","author":"Fulk","year":"2004","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b0850","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0091-3057(81)90057-5","article-title":"Repeated administration of pergolide to rats attenuates the acute elevation of serum corticosterone by pergolide","volume":"15","author":"Fuller","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0855","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/COH.0000000000000019","article-title":"Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients","volume":"9","author":"Funderburg","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.brainres.2019.146398_b0860","article-title":"S-adenosyl methionine (SAMe) for depression in adults","volume":"10","author":"Galizia","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0865","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bjid.2016.10.004","article-title":"Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection","volume":"21","author":"Galvao-Lima","year":"2017","journal-title":"Braz. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0870","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/WCO.0b013e32834695fb","article-title":"Current understanding of HIV-associated neurocognitive disorders pathogenesis","volume":"24","author":"Gannon","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.brainres.2019.146398_b0875","first-page":"1363","article-title":"Use of atypical antipsychotics in the elderly: a clinical review","volume":"9","author":"Gareri","year":"2014","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0880","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2353\/ajpath.2009.081067","article-title":"Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse","volume":"175","author":"Gaskill","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2019.146398_b0885","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1742-2094-9-203","article-title":"Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse","volume":"9","author":"Gaskill","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0890","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11481-013-9443-y","article-title":"Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND","volume":"8","author":"Gaskill","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108232","article-title":"Dopamine receptor activation increases HIV entry into primary human macrophages","volume":"9","author":"Gaskill","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b0900","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/npp.2013.135","article-title":"The HIV antiretroviral drug efavirenz has LSD-like properties","volume":"38","author":"Gatch","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019617","article-title":"Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy","volume":"6","author":"Gay","year":"2011","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b0910","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/QAD.0b013e3283463c07","article-title":"Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection","volume":"25","author":"Gay","year":"2011","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0915","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11904-015-0266-8","article-title":"Neuropathology of HAND With suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered","volume":"12","author":"Gelman","year":"2015","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0920","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002030-198909000-00001","article-title":"Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial","volume":"3","author":"Gelmon","year":"1989","journal-title":"Aids"},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b0925","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2967\/jnumed.108.052688","article-title":"Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism","volume":"49","author":"Georgiou","year":"2008","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0930","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00210-004-0984-8","article-title":"Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat","volume":"370","author":"Gerlach","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b0935","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hup.964","article-title":"Circadian rhythm disturbances in depression","author":"Germain","year":"2008","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0940","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1468-1293.2006.00350.x","article-title":"Depression and neurocognitive performance in individuals with HIV\/AIDS: 2-year follow-up","volume":"7","author":"Gibbie","year":"2006","journal-title":"HIV Med"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b0945","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0378-5955(94)90138-4","article-title":"Piribedil affects dopamine turnover in cochleas stimulated by white noise","volume":"79","author":"Gil-Loyzaga","year":"1994","journal-title":"Hear. Res."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b0950","first-page":"19","article-title":"L-methylfolate plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode","volume":"8","author":"Ginsberg","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.brainres.2019.146398_b0955","first-page":"749","article-title":"Polypharmacy in the HIV-infected older adult population","volume":"8","author":"Gleason","year":"2013","journal-title":"Clin. Interv. Aging"},{"issue":"Pt 1","key":"10.1016\/j.brainres.2019.146398_b0960","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainresbull.2016.04.011","article-title":"Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and \u03b1-pyrrolidinovalerophenone (\u03b1-PVP)","volume":"126","author":"Glennon","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"8712","key":"10.1016\/j.brainres.2019.146398_b0965","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","article-title":"Enhancement of recovery from psychiatric illness by methylfolate","volume":"336","author":"Godfrey","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2019.146398_b0970","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbi.2016.03.025","article-title":"Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder","volume":"56","author":"Goldsmith","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b0975","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13365-011-0055-0","article-title":"Clinical contributors to cerebral white matter integrity in HIV-infected individuals","volume":"17","author":"Gongvatana","year":"2011","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b0980","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13365-013-0162-1","article-title":"Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy","volume":"19","author":"Gongvatana","year":"2013","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b0985","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0B013E31822D490A","article-title":"Depression and HIV\/AIDS treatment nonadherence: a review and meta-analysis","volume":"58","author":"Gonzalez","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b0990","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0028-3908(75)90125-2","article-title":"Benztropine-induced release of dopamine from brain in vivo","volume":"14","author":"Goodale","year":"1975","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b0995","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2352-3018(17)30098-X","article-title":"Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study","volume":"4","author":"Goodkin","year":"2017","journal-title":"Lancet HIV"},{"issue":"16","key":"10.1016\/j.brainres.2019.146398_b1000","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/0006-2952(83)90684-6","article-title":"Relationship between the ability of some neuroleptics to enhance striatal [3H]dopamine release and their lipophilicity","volume":"32","author":"Goosey","year":"1983","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-979485","article-title":"Efficacy of paroxetine for the treatment of depression in the context of HIV infection","volume":"30","author":"Grassi","year":"1997","journal-title":"Pharmacopsychiatry"},{"issue":"17","key":"10.1016\/j.brainres.2019.146398_b1010","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1097\/QAD.0b013e32831883f9","article-title":"Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals","volume":"22","author":"Greenbaum","year":"2008","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0091270003251864","article-title":"Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone","volume":"43","author":"Greenblatt","year":"2003","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jgs.12695","article-title":"Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection","volume":"62","author":"Greene","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biopsych.2015.11.003","article-title":"The selective serotonin reuptake inhibitor citalopram decreases human immunodeficiency virus receptor and coreceptor expression in immune cells","volume":"80","author":"Greeson","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1030","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/09540120903280901","article-title":"Loneliness and HIV-related stigma explain depression among older HIV-positive adults","volume":"22","author":"Grov","year":"2010","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155100","article-title":"Relevance of interleukin-6 and D-dimer for serious Non-AIDS morbidity and death among hiv-positive adults on suppressive antiretroviral therapy","volume":"11","author":"Grund","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118531","article-title":"Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles","volume":"10","author":"Guaraldi","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/endo-106-2-526","article-title":"Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration*","volume":"106","author":"Gudelsky","year":"1980","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(94)90669-6","article-title":"Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists","volume":"264","author":"Gudelsky","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1461145707008383","article-title":"Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions","volume":"11","author":"Guiard","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/hiv.12104","article-title":"Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs","volume":"15","author":"Guti\u00e9rrez","year":"2014","journal-title":"HIV Med."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1065","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.neuroimage.2009.10.037","article-title":"Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV","volume":"49","author":"Hammoud","year":"2010","journal-title":"NeuroImage"},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b1070","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/dkn193","article-title":"Impact of depression on HIV outcomes in the HAART era","volume":"62","author":"Hartzell","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00406-016-0692-7","article-title":"Reduction of dopamine D(2\/3) receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys","volume":"267","author":"Hashimoto","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2131\/jts.42.539","article-title":"Alpha-PVP induces the rewarding effect via activating dopaminergic neuron","volume":"42","author":"Hataoka","year":"2017","journal-title":"J. Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1071\/SH11017","article-title":"Comorbidities and depression in older adults with HIV","volume":"8","author":"Havlik","year":"2011","journal-title":"Sex Health"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pbb.2008.03.016","article-title":"New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD","volume":"90","author":"Heal","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-3565(25)09511-4","article-title":"The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis","volume":"273","author":"Hemby","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00172790","article-title":"Comparison between radiolabelled and endogenous dopamine release from rat striatal slices: effects of electrical field stimulation and regulation by D2-autoreceptors","volume":"335","author":"Herdon","year":"1987","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/JNC.0000000000000040","article-title":"Screening for HIV-associated neurocognitive impairment: relevance of psychological factors and era of commencement of antiretroviral therapy","volume":"30","author":"Herrmann","year":"2019","journal-title":"J. Assoc. Nurses AIDS Care"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b1115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02245607","article-title":"Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain","volume":"124","author":"Hertel","year":"1996","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1120","first-page":"100","article-title":"Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion","volume":"29","author":"Hesse","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2019.146398_b1125","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/QAI.0b013e31825a3668","article-title":"HIV and aging: state of knowledge and areas of critical need for research. a report to the NIH Office of AIDS Research by the HIV and Aging Working Group","volume":"60","author":"High","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11904-017-0356-x","article-title":"Inflammation, immune activation, and antiretroviral therapy in HIV","volume":"14","author":"Hileman","year":"2017","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1345\/aph.1R343","article-title":"Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics","volume":"47","author":"Hill","year":"2013","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1176\/jnp.13.2.248","article-title":"Methylphenidate improves HIV-1-associated cognitive slowing","volume":"13","author":"Hinkin","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1037\/pas0000040","article-title":"Psychometric validation of the BDI-II among HIV-positive CHARTER study participants","volume":"27","author":"Hobkirk","year":"2015","journal-title":"Psychol. Assess."},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b1150","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/hiv.12468","article-title":"Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients","volume":"18","author":"Hoffmann","year":"2017","journal-title":"HIV Med."},{"issue":"8465","key":"10.1016\/j.brainres.2019.146398_b1160","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(85)92706-0","article-title":"Extrapyramidal symptoms in AIDS patients given low-dose metoclopramide or chlorpromazine","volume":"2","author":"Hollander","year":"1985","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b1165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(94)91558-X","article-title":"Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study","volume":"633","author":"Hondo","year":"1994","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b1170","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI98968","article-title":"T cells establish and maintain CNS viral infection in HIV-infected humanized mice","volume":"128","author":"Honeycutt","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b1175","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-013-1086-x","article-title":"Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10\/10-repeat allele which is more frequent in HIV-infected individuals","volume":"120","author":"Horn","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2019.146398_b1180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000343980","article-title":"Glucocorticoids and inflammation: a double-headed sword in depression? How do neuroendocrine and inflammatory pathways interact during stress to contribute to the pathogenesis of depression?","volume":"28","author":"Horowitz","year":"2013","journal-title":"Mod Trends Pharmacopsychiatry"},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b1185","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1176\/ajp.148.11.1558","article-title":"Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy","volume":"148","author":"Hriso","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.brainres.2019.146398_b1190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/13550280903296346","article-title":"Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage","volume":"15","author":"Hu","year":"2009","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-005-0206-1","article-title":"Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex","volume":"185","author":"Huang","year":"2006","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b1200","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/jcbfm.2015.128","article-title":"De novo expression of dopamine D2 receptors on microglia after stroke","volume":"35","author":"Huck","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1205","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.neuropharm.2008.06.045","article-title":"Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants","volume":"55","author":"Hwang","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(95)00264-L","article-title":"Effect of antidepressants on striatal and accumbens extracellular dopamine levels","volume":"281","author":"Ichikawa","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b1215","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.285.11.1466","article-title":"Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study","volume":"285","author":"Ickovics","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S1355617715000156","article-title":"HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study","volume":"21","author":"Ipser","year":"2015","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s004010051139","article-title":"Neuronal damage of the substantia nigra in HIV-1 infected brains","volume":"99","author":"Itoh","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2019.146398_b1230","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","article-title":"The inflammasome: pathways linking psychological stress, depression, and systemic illnesses","volume":"31","author":"Iwata","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1235","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s11682-016-9632-4","article-title":"Resting-state subcortical functional connectivity in HIV-infected patients on long-term cART","volume":"11","author":"Janssen","year":"2017","journal-title":"Brain Imaging Behav."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1240","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/381454","article-title":"HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan Cote d'Ivoire","volume":"189","author":"Jennes","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.brainres.2019.146398_b1245","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbi.2017.07.005","article-title":"Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection","volume":"66","author":"Jha","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131389","article-title":"Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease","volume":"10","author":"Jones","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2019.146398_b1255","article-title":"HIV-1 RNA detected in the CNS after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells","author":"Joseph","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b1260","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/phar.1670","article-title":"Antiretroviral treatment efficacy and safety in older HIV-infected adults","volume":"35","author":"Jourjy","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1265","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00512936","article-title":"Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution","volume":"333","author":"Juorio","year":"1986","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b1270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00002030-200401001-00008","article-title":"Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: veterans aging cohort five-site study","volume":"18","author":"Justice","year":"2004","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1275","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1258\/ijsa.2009.009451","article-title":"Depression associated with antiretroviral drug therapy in HIV: case report and overview","volume":"23","author":"Kaestner","year":"2012","journal-title":"Int. J. STD AIDS"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1280","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1471-4159.1977.tb10675.x","article-title":"Dopamine biosynthesis from L-tyrosine and L-phenylalanine in rat brain synaptosomes: preferential use of newly accumulated precursors","volume":"28","author":"Kapatos","year":"1977","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1285","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1476-5381.1994.tb17152.x","article-title":"Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain","volume":"113","author":"Karoum","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b1290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbi.2017.03.002","article-title":"NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings","volume":"64","author":"Kaufmann","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1295","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(77)90319-3","article-title":"Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain","volume":"41","author":"Kehr","year":"1977","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b1300","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00702-007-0719-3","article-title":"Continuous delivery of rotigotine decreases extracellular dopamine suggesting continuous receptor stimulation","volume":"114","author":"Kehr","year":"2007","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179874","article-title":"Diminished physical function in older HIV-infected adults in the Southeastern U.S. despite successful antiretroviral therapy","volume":"12","author":"Khoury","year":"2017","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0736-5748(00)00022-8","article-title":"Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB\/c mice","volume":"18","author":"Kita","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2019.146398_b1315","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2010.08.026","article-title":"Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats","volume":"647","author":"Kitaichi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b1320","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2147\/NDT.S49261","article-title":"Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report","volume":"9","author":"Kitaichi","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1325","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1570159X1305151013200032","article-title":"Treatment-resistant late-life depression: challenges and perspectives","volume":"13","author":"Kn\u00f6chel","year":"2015","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1330","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11481-018-9809-2","article-title":"Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-infected aviremic individuals on suppressive antiretroviral therapy","volume":"14","author":"Ko","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1335","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis","volume":"55","author":"Kohler","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/mp.2017.190","article-title":"The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders","volume":"23","author":"Kokkinou","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1345","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci."},{"issue":"5\u20136","key":"10.1016\/j.brainres.2019.146398_b1350","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s007020200063","article-title":"Parkinsonism in HIV dementia","volume":"109","author":"Koutsilieri","year":"2002","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1355","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s007020170051","article-title":"Neurotransmission in HIV associated dementia: a short review","volume":"108","author":"Koutsilieri","year":"2001","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1360","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nbd.2009.12.015","article-title":"HIV-1 neuroimmunity in the era of antiretroviral therapy","volume":"37","author":"Kraft-Terry","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1365","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0278-5846(01)00222-6","article-title":"Dopamine receptors and learned helplessness in the rat: an autoradiographic study","volume":"26","author":"Kram","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1370","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mp.2013.155","article-title":"Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis","volume":"19","author":"Kreisel","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1375","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0006-3223(02)01472-5","article-title":"Comorbidity of depression with other medical diseases in the elderly","volume":"52","author":"Krishnan","year":"2002","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1380","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0924-8579(99)00157-0","article-title":"Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia","volume":"14","author":"Kristiansen","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13550280902973952","article-title":"Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains","volume":"15","author":"Kumar","year":"2009","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1390","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13365-010-0003-4","article-title":"Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance","volume":"17","author":"Kumar","year":"2011","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1395","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00213-011-2597-5","article-title":"Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC","volume":"221","author":"Ladurelle","year":"2012","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1400","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages","volume":"12","author":"Lagathu","year":"2007","journal-title":"Antivir. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.brainres.2019.146398_b1405","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1097\/QAD.0000000000001441","article-title":"Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers","volume":"31","author":"Lagathu","year":"2017","journal-title":"Aids"},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b1410","first-page":"787","article-title":"Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders","volume":"57","author":"Lambert","year":"2000","journal-title":"JAMA Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2019.146398_b1415","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-008-1342-1","article-title":"Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex","volume":"202","author":"Lapish","year":"2009","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1420","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jnr.490280313","article-title":"Cerebrospinal fluid catecholamine metabolites in HIV-infected patients","volume":"28","author":"Larsson","year":"1991","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1425","first-page":"324","article-title":"Decreased whole blood 5-hydroxytryptamine (serotonin) in AIDS patients","volume":"1","author":"Launay","year":"1988","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1430","first-page":"159","article-title":"Serotonin and human immunodeficiency viruses","volume":"31","author":"Launay","year":"1989","journal-title":"Nouv. Rev. Fr. Hematol."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b1435","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.bbi.2011.05.006","article-title":"Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression","volume":"25","author":"Lawson","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1440","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bbamem.2006.11.001","article-title":"Seven transmembrane receptors: a brief personal retrospective","volume":"1768","author":"Lefkowitz","year":"2007","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1445","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0006-3223(03)00323-8","article-title":"HIV disease progression: depression, stress, and possible mechanisms","volume":"54","author":"Leserman","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1450","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PSY.0b013e3181777a5f","article-title":"Role of depression, stress, and trauma in HIV disease progression","volume":"70","author":"Leserman","year":"2008","journal-title":"Psychosom. Med."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1455","first-page":"45","article-title":"Neurologic complications of HIV disease and their treatment","volume":"18","author":"Letendre","year":"2010","journal-title":"Top HIV Med"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1460","first-page":"62","article-title":"A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir","volume":"35","author":"Levin","year":"2001","journal-title":"Psychopharmacol. Bull."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1465","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130050551","article-title":"Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum","volume":"136","author":"Li","year":"1998","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2019.146398_b1470","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain","volume":"493","author":"Li","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b1475","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.4049\/jimmunol.1100099","article-title":"IFN-\u03b3 mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the \u03b2-catenin pathway (DKK1) in a STAT 3-dependent manner","volume":"186","author":"Li","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1480","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1570162X14666161006121455","article-title":"Astrocytes as an HIV reservoir: mechanism of HIV infection","volume":"14","author":"Li","year":"2016","journal-title":"Curr. HIV Res."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1485","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00213-003-1418-x","article-title":"A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens","volume":"167","author":"Li","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146398_b1490","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2018.08.021","article-title":"Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder","volume":"241","author":"Li","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainres.2019.146398_b1495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.011","article-title":"Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy","volume":"83","author":"Li","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1500","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s12035-016-9717-5","article-title":"Pramipexole, a dopamine D2\/D3 receptor-preferring agonist, prevents experimental autoimmune encephalomyelitis development in mice","volume":"54","author":"Lieberknecht","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1505","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1310\/hct0903-177","article-title":"Determination of the underlying cause of death in three multicenter international HIV clinical trials","volume":"9","author":"Lifson","year":"2008","journal-title":"HIV Clin. Trials"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1510","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0022-3565(24)29568-9","article-title":"Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex","volume":"297","author":"Linner","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1515","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1471-4159.2011.07549.x","article-title":"Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120","volume":"120","author":"Lisi","year":"2012","journal-title":"J. Neurochem."},{"issue":"13","key":"10.1016\/j.brainres.2019.146398_b1520","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1128\/JVI.78.13.7288-7289.2004","article-title":"CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor","volume":"78","author":"Liu","year":"2004","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1525","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1530","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/hiv.12710","article-title":"Discontinuation of dolutegravir, elvitegravir\/cobicistat and raltegravir because of toxicity in a prospective cohort","volume":"20","author":"Llibre","year":"2019","journal-title":"HIV Med."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1535","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MED.0b013e328344556e","article-title":"Dyslipidemia and lipid management in HIV-infected patients","volume":"18","author":"Lo","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1540","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1545","first-page":"184","article-title":"Dopamine systems in human immunodeficiency virus-associated dementia","volume":"12","author":"Lopez","year":"1999","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.brainres.2019.146398_b1550","article-title":"Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients","author":"Ma","year":"2015","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.brainres.2019.146398_b1555","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijid.2018.02.009","article-title":"Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: a cross-sectional study","volume":"70","author":"Maciel","year":"2018","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1560","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s13365-010-0008-z","article-title":"Successful cognitive aging in persons living with HIV infection","volume":"17","author":"Malaspina","year":"2011","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1565","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13365-018-0616-6","article-title":"An SIV macaque model of SIV and HAND: the need for adjunctive therapies in HIV that target activated monocytes and macrophages","volume":"24","author":"Mallard","year":"2018","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1570","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","article-title":"HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation","volume":"12","author":"Mamik","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1575","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/bjp.2008.80","article-title":"Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT(1A) receptors","volume":"154","author":"Man\u00e9glier","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b1580","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/00002030-200007070-00034","article-title":"A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age","volume":"14","author":"Manfredi","year":"2000","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1585","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1590","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1471-4159.2002.01212.x","article-title":"Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function","volume":"83","author":"Maragos","year":"2002","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1595","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/157015908787386078","article-title":"Triple reuptake inhibitors: the next generation of antidepressants","volume":"6","author":"Marks","year":"2008","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055279","article-title":"Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women","volume":"8","author":"Martin","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1605","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157015912800604542","article-title":"Immunomodulation mechanism of antidepressants: interactions between serotonin\/norepinephrine balance and Th1\/Th2 balance","volume":"10","author":"Martino","year":"2012","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b1610","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/jac\/dkr248","article-title":"Ageing with HIV: medication use and risk for potential drug-drug interactions","volume":"66","author":"Marzolini","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2019.146398_b1615","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2010.04.043","article-title":"Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport","volume":"640","author":"Matsuo","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b1620","article-title":"where is dopamine and how do immune cells see it?: Dopamine-mediated immune cell function in health and disease","author":"Matt","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b1625","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.coph.2015.10.009","article-title":"Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation","volume":"26","author":"Matt","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1630","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3928\/0098-9134-20030401-05","article-title":"Recognizing and preventing drug interactions in older adults with HIV","volume":"29","author":"McLennon","year":"2003","journal-title":"J. Gerontol. Nurs."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1635","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0028-3908(83)90240-X","article-title":"Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat","volume":"22","author":"McMillen","year":"1983","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1640","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2019.146398_b1645","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2016.00614","article-title":"Stimulation of PBMC and monocyte-derived macrophages via toll-like receptor activates innate immune pathways in HIV-infected patients on virally suppressive combination antiretroviral therapy","volume":"7","author":"Merlini","year":"2016","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.brainres.2019.146398_b1650","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1097\/00001756-200112210-00052","article-title":"Lower dopamine transporter binding potential in striatum during depression","volume":"12","author":"Meyer","year":"2001","journal-title":"NeuroReport"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1655","article-title":"Are Serotonin Alterations the Link between Thrombocytopenia and Poor Immune Status among HIV Infected Individuals?","volume":"2","author":"Miguez-Burbano","year":"2014","journal-title":"J. AIDS Clin. Res."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b1660","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/09540121.2017.1281877","article-title":"Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study","volume":"29","author":"Milanini","year":"2017","journal-title":"AIDS Care"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1665","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11904-017-0361-0","article-title":"Differentiating HIV-associated neurocognitive disorders from Alzheimer's disease: an emerging issue in geriatric NeuroHIV","volume":"14","author":"Milanini","year":"2017","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1670","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-Hydroxytryptamine<sub>2C<\/sub> receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1675","first-page":"216","article-title":"The methylation, neurotransmitter, and antioxidant connections between folate and depression","volume":"13","author":"Miller","year":"2008","journal-title":"Altern. Med. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1680","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1685","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1471-4159.1986.tb00777.x","article-title":"Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices","volume":"47","author":"Milner","year":"1986","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b1690","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(94)90821-4","article-title":"Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism","volume":"662","author":"Mizoguchi","year":"1994","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1695","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1472-8206.1990.tb00489.x","article-title":"Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine","volume":"4","author":"Mj\u00f6rndal","year":"1990","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1700","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/syn.890040209","article-title":"Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine","volume":"4","author":"Moghaddam","year":"1989","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M14-0293","article-title":"Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data","volume":"161","author":"Mollan","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.brainres.2019.146398_b1710","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1800587","article-title":"Low-dose maraviroc, an antiretroviral drug, attenuates the infiltration of T cells into the central nervous system and protects the nigrostriatum in hemiparkinsonian monkeys","author":"Mondal","year":"2019","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1715","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0000000000001404","article-title":"Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy","volume":"31","author":"Montoya","year":"2017","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1720","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.brainresrev.2007.10.006","article-title":"Glutamate\u2013dopamine\u2013GABA interactions in the aging basal ganglia","volume":"58","author":"Mora","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1725","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00210-001-0497-7","article-title":"Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex","volume":"365","author":"Nakayama","year":"2002","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1730","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1735","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11920-014-0530-4","article-title":"Depression in HIV infected patients: a review","volume":"17","author":"Nanni","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1740","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.EJ17-0276","article-title":"Efficacy and safety of metyrosine in pheochromocytoma\/paraganglioma: a multi-center trial in Japan","volume":"65","author":"Naruse","year":"2018","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1745","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection","volume":"187","author":"Nasi","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1750","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/026988110001400305","article-title":"Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia","volume":"14","author":"Nath","year":"2000","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1755","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ana.410190603","article-title":"The AIDS dementia complex: II. Neuropathology","volume":"19","author":"Navia","year":"1986","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1760","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.imbio.2016.07.001","article-title":"The role of macrophages in anti-inflammatory activity of antidepressant drugs","volume":"222","author":"Nazimek","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.brainres.2019.146398_b1765","doi-asserted-by":"crossref","first-page":"5897298","DOI":"10.1155\/2017\/5897298","article-title":"Aging in HIV-infected subjects: a new scenario and a new view","volume":"2017","author":"Negredo","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b1770","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"3953","key":"10.1016\/j.brainres.2019.146398_b1775","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.170.3953.76","article-title":"L-Dopa-induced release of cerebral monoamines","volume":"170","author":"Ng","year":"1970","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1780","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/COH.0b013e32833ed6f4","article-title":"Biomarkers of immune dysfunction in HIV","volume":"5","author":"Nixon","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b1785","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.50.3.645","article-title":"A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders","volume":"50","author":"No author","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.146398_b1790","article-title":"Role of macrophage dopamine receptors in mediating cytokine production: implications for neuroinflammation in the context of HIV-associated neurocognitive disorders","author":"Nolan","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b1795","article-title":"The role of catecholamines in HIV neuropathogenesis","author":"Nolan","year":"2018","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1800","first-page":"7","article-title":"Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum","volume":"7","author":"Nomikos","year":"1992","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl E1","key":"10.1016\/j.brainres.2019.146398_b1805","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1810","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2013.05.005","article-title":"Prevalence and correlates of depression among HIV-infected and -affected older people in rural South Africa","volume":"151","author":"Nyirenda","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1815","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharep.2013.08.002","article-title":"Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture","volume":"66","author":"Obuchowicz","year":"2014","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1820","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1037\/1064-1297.8.1.133","article-title":"Antidepressant drugs appear to enhance cocaine-induced toxicity","volume":"8","author":"O'Dell","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1825","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF00169830","article-title":"Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain","volume":"349","author":"Oishi","year":"1994","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1830","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1440-1681.1993.tb01679.x","article-title":"Effects of reserpine on the content and uptake of dopamine and noradrenaline in rabbit arteries","volume":"20","author":"Okada","year":"1993","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1835","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0741-8329(97)00101-8","article-title":"Nefazodone attenuates the behavioral and neurochemical effects of ethanol","volume":"15","author":"Olausson","year":"1998","journal-title":"Alcohol"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2019.146398_b1840","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejphar.2012.03.003","article-title":"Effects of the histamine H1 receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward","volume":"683","author":"Oleson","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1845","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000087107","article-title":"Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats","volume":"12","author":"O'Mahony","year":"2005","journal-title":"NeuroImmunoModulation"},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b1850","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1468-1293.2006.00420.x","article-title":"Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients","volume":"7","author":"Orlando","year":"2006","journal-title":"HIV Med."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1855","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-018-0490-9","article-title":"The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects","volume":"25","author":"Osuji","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1860","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1471-4159.2012.07677.x","article-title":"Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens","volume":"121","author":"Owesson-White","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2019.146398_b1865","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2014.04.007","article-title":"Microglial NLRP3 inflammasome activation mediates IL-1beta-related inflammation in prefrontal cortex of depressive rats","volume":"41","author":"Pan","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b1870","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b1875","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/09540121.2011.565027","article-title":"Sexual risk taking and club drug use across three age cohorts of HIV-positive gay and bisexual men in New York City","volume":"23","author":"Pappas","year":"2011","journal-title":"AIDS Care"},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b1880","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1885","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1471-4159.1993.tb05864.x","article-title":"Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine","volume":"60","author":"Parsons","year":"1993","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b1890","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/gerona\/glt168","article-title":"Is HIV a model of accelerated or accentuated aging?","volume":"69","author":"Pathai","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1895","doi-asserted-by":"crossref","first-page":"16947","DOI":"10.1038\/s41598-018-35271-0","article-title":"Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy","volume":"8","author":"Peltenburg","year":"2018","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.brainres.2019.146398_b1900","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1097\/QAD.0000000000000797","article-title":"The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial","volume":"29","author":"Pence","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1905","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapsychiatry.2017.4726","volume":"75","author":"Pence","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b1910","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0028-3908(76)90056-3","article-title":"Metoclopramide and dopamine receptor blockade","volume":"15","author":"Peringer","year":"1976","journal-title":"Neuropharmacology"},{"issue":"5\u20136","key":"10.1016\/j.brainres.2019.146398_b1915","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/FBP.0b013e32830cd80f","article-title":"Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions","volume":"19","author":"Perona","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2019.146398_b1920","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pharmtox-010617-052823","article-title":"Inflammatory mediators in mood disorders: therapeutic opportunities","volume":"58","author":"Pfau","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6932","key":"10.1016\/j.brainres.2019.146398_b1925","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature01476","article-title":"Subsecond dopamine release promotes cocaine seeking","volume":"422","author":"Phillips","year":"2003","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b1930","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165344","article-title":"Depression and diagnosis of neurocognitive impairment in HIV-positive patients","volume":"49","author":"Pinheiro","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1935","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11481-017-9749-2","article-title":"Dopaminergic regulation of innate immunity: a review","volume":"12","author":"Pinoli","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b1940","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2004.09.053","article-title":"The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex","volume":"504","author":"Pira","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1945","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-8993(02)03055-X","article-title":"\u03949-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study","volume":"948","author":"Pistis","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.146398_b1950","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2019.0801","article-title":"Assessment of striatal dopamine transporter binding in individuals with major depressive disorder: in vivo positron emission tomography and postmortem evidence","author":"Pizzagalli","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1955","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/QAD.0000000000000151","article-title":"HIV infection and the fronto-striatal system: a systematic review and meta-analysis of fMRI studies","volume":"28","author":"Plessis","year":"2014","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b1960","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.qai.0000245886.51262.67","article-title":"Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine\/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes\u2013a 96-week analysis","volume":"43","author":"Pozniak","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.brainres.2019.146398_b1965","unstructured":"Prevention, C.f.D.C.a., 2016. HIV among people aged 50 and older. pp. 25."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b1970","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1476-5381.1995.tb16684.x","article-title":"Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area","volume":"116","author":"Prisco","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b1975","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12035-011-8195-z","article-title":"Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders\/HIV-associated dementia","volume":"44","author":"Purohit","year":"2011","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1980","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1176\/ajp.151.4.516","article-title":"Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness","volume":"151","author":"Rabkin","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b1985","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11904-008-0025-1","article-title":"HIV and depression: 2008 review and update","volume":"5","author":"Rabkin","year":"2008","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1990","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.09m05171bro","article-title":"Modafinil treatment for fatigue in HIV\/AIDS: a randomized placebo-controlled study","volume":"71","author":"Rabkin","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b1995","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/YCO.0b013e32834b9db6","article-title":"Inflammatory mechanisms in major depressive disorder","volume":"24","author":"Raedler","year":"2011","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2000","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-alpha: recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0019-5545.42391","article-title":"Understanding nutrition, depression and mental illnesses","volume":"50","author":"Rao","year":"2008","journal-title":"Indian J. Psychiatry"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13365-015-0346-y","article-title":"Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment","volume":"21","author":"Rappaport","year":"2015","journal-title":"J. Neurovirol."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b2020","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S2352-3018(15)00077-6","article-title":"Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study","volume":"2","author":"Rasmussen","year":"2015","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32834273ad","article-title":"Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation","volume":"25","author":"Regidor","year":"2011","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002130100836","article-title":"Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?","volume":"159","author":"Renard","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.brainres.2006.09.034","article-title":"Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA)","volume":"1123","author":"Reynolds","year":"2006","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b2040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cpr.2011.07.004","article-title":"Prevalence and clinical course of depression: a review","volume":"31","author":"Richards","year":"2011","journal-title":"Clin. Psychol. Rev."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2045","first-page":"1000276","article-title":"Depression correlates with increased plasma levels of inflammatory cytokines and a dysregulated oxidant\/antioxidant balance in HIV-1-infected subjects undergoing antiretroviral therapy","volume":"5","author":"Rivera-Rivera","year":"2014","journal-title":"J. Clin. Cell. Immunol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2050","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000423","article-title":"Impact of depression and inflammation on the progression of HIV disease","volume":"7","author":"Rivera-Rivera","year":"2016","journal-title":"J. Clin. Cell Immunol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2055","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv082","article-title":"The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials","volume":"19","author":"Rosenblat","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2060","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.410220605","article-title":"The metabolic pathology of the AIDS dementia complex","volume":"22","author":"Rottenberg","year":"1987","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b2065","first-page":"1133","article-title":"Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia","volume":"37","author":"Rottenberg","year":"1996","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2070","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuropharm.2012.07.008","article-title":"Lisdexamfetamine and immediate release d-amfetamine \u2013 differences in pharmacokinetic\/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity","volume":"63","author":"Rowley","year":"2012","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b2075","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1210\/en.2010-0745","article-title":"Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let\u2019s seek the balance","volume":"151","author":"Rub\u00ed","year":"2010","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11904-017-0347-y","article-title":"Healthy aging in older women living with HIV Infection: a systematic review of psychosocial factors","volume":"14","author":"Rubtsova","year":"2017","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b2085","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ebiom.2015.07.025","article-title":"During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR\/DP\/DQ","volume":"2","author":"Ruggiero","year":"2015","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2090","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy032","article-title":"Factors associated with persistence of plasma HIV-1 RNA during long-term continuously suppressive firstline antiretroviral Therapy","volume":"5","author":"Ruggiero","year":"2018","journal-title":"Open Forum Infect. Dis."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2095","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.celrep.2017.01.027","article-title":"Astrocytes resist HIV-1 fusion but engulf infected macrophage material","volume":"18","author":"Russell","year":"2017","journal-title":"Cell reports"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13365-017-0587-z","article-title":"Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial","volume":"24","author":"Sacktor","year":"2018","journal-title":"J. Neurovirol."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2105","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjp.0703139","article-title":"Postsynaptic 5-hydroxytryptamine1A receptor activation increases in vivo dopamine release in rat prefrontal cortex","volume":"129","author":"Sakaue","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.brainres.2019.146398_b2110","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00018-012-0962-0","article-title":"Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases","volume":"69","author":"Salminen","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1525-1497.2000.06219.x","article-title":"Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression","volume":"15","author":"Sambamoorthi","year":"2000","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jac\/dkw403","article-title":"Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients","volume":"72","author":"Sandkovsky","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b2125","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/09540121.2011.564115","article-title":"What do we know about older adults and HIV? A review of social and behavioral literature","volume":"23","author":"Sankar","year":"2011","journal-title":"AIDS Care"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02246584","article-title":"Effects of trepelennamine on brain monoamine turnover in morphine dependent and abstinent mice","volume":"123","author":"San-Martin-Clark","year":"1996","journal-title":"Psychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.brainres.2019.146398_b2135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pscychresns.2006.03.001","article-title":"Dopamine transporter binding in depressed patients with anhedonia","volume":"147","author":"Sarchiapone","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2019.146398_b2140","series-title":"Evolution of Depressive Symptoms in Human Immunodeficiency Virus-infected Patients Entering Primary Care","first-page":"76","author":"Savetsky","year":"2001"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder\u2013pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1_supplement","key":"10.1016\/j.brainres.2019.146398_b2150","doi-asserted-by":"crossref","first-page":"p. 134.3","DOI":"10.1096\/fasebj.29.1_supplement.134.3","article-title":"Oral S-adenosylmethionine (SAM) Administration Increases Whole Brain Concentrations of Dopamine and Norepinephrine in Rats","volume":"29","author":"Schalinske","year":"2015","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00702-010-0415-6","article-title":"Increased dopaminergic neurotransmission in therapy-naive asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses","volume":"117","author":"Scheller","year":"2010","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2160","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1111\/hiv.12538","article-title":"Severe depression as a neuropsychiatric side effect induced by dolutegravir","volume":"19","author":"Scheper","year":"2018","journal-title":"HIV Med"},{"issue":"23","key":"10.1016\/j.brainres.2019.146398_b2165","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1523\/JNEUROSCI.0622-17.2017","article-title":"Selective vulnerability of striatal D2 versus D1 dopamine receptor-expressing medium spiny neurons in HIV-1 Tat transgenic male mice","volume":"37","author":"Schier","year":"2017","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.brainres.2019.146398_b2170","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/01.wnl.0000268487.78753.0f","article-title":"A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment","volume":"69","author":"Schifitto","year":"2007","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.brainres.2019.146398_b2175","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1212\/WNL.0b013e3181c51a48","article-title":"Selegiline and oxidative stress in HIV-associated cognitive impairment","volume":"73","author":"Schifitto","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1301087","article-title":"Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors","volume":"32","author":"Schilstrom","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)36395-5","article-title":"Neurochemical characteristics of amisulpride, an atypical dopamine D2\/D3 receptor antagonist with both presynaptic and limbic selectivity","volume":"280","author":"Schoemaker","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b2190","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study","volume":"59","author":"Schouten","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0145445511425231","article-title":"The influence of depression on the progression of HIV: direct and indirect effects","volume":"36","author":"Schuster","year":"2012","journal-title":"Behav. Modif."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/cid\/ciw683","article-title":"Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection","volume":"64","author":"Sereti","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.brainres.2019.146398_b2205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijid.2018.10.011","article-title":"Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study","volume":"79","author":"Serr\u00e3o","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.brainres.2019.146398_b2210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchemneu.2017.01.004","article-title":"Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter","volume":"83\u201384","author":"Shekar","year":"2017","journal-title":"J. Chem. Neuroanat."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b2215","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0006-3223(00)00994-X","article-title":"3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity","volume":"48","author":"Sheline","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b2220","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2174\/138920011796504527","article-title":"Age-related changes in pharmacokinetics","volume":"12","author":"Shi","year":"2011","journal-title":"Curr. Drug Metab."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4236\/wja.2011.14020","article-title":"The impact of depressive symptoms on neuropsychological performance tests in HIV-infected individuals: a study of the hawaii aging with HIV cohort","volume":"1","author":"Shimizu","year":"2011","journal-title":"World J. AIDS"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2230","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pnpbp.2004.01.013","article-title":"Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine","volume":"28","author":"Shioda","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QAI.0b013e31825ddbbf","article-title":"HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease","volume":"61","author":"Shive","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"19","key":"10.1016\/j.brainres.2019.146398_b2240","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/ac0608218","article-title":"Monitoring dopamine in vivo by microdialysis sampling and on-line CE-laser-induced fluorescence","volume":"78","author":"Shou","year":"2006","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2245","first-page":"19","article-title":"Effects of serotonin and melanin on in vitro HIV-1 infection","volume":"10","author":"Sidibe","year":"1996","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2250","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/S1516-44462012000200008","article-title":"Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy","volume":"34","author":"Silveira","year":"2012","journal-title":"Braz. J. Psychiatry"},{"issue":"14","key":"10.1016\/j.brainres.2019.146398_b2255","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/QAD.0b013e3282ed6338","article-title":"Risk of cancers during interrupted antiretroviral therapy in the SMART study","volume":"21","author":"Silverberg","year":"2007","journal-title":"Aids"},{"key":"10.1016\/j.brainres.2019.146398_b2260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fpsyt.2012.00082","article-title":"Quetiapine and buspirone both elevate cortical levels of noradrenaline and dopamine in vivo, but do not have synergistic effects","volume":"3","author":"Silverstone","year":"2012","journal-title":"Front. Psychiatry"},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b2265","first-page":"6","article-title":"HIV in older adults","volume":"63","author":"Simone","year":"2008","journal-title":"Geriatrics"},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b2270","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.npp.1300786","article-title":"Self-administered heroin and cocaine combinations in the rat: additive reinforcing effects-supra-additive effects on nucleus accumbens extracellular dopamine","volume":"31","author":"Smith","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00421267","article-title":"Effects of single and multiple dose LSD on endogenous levels of brain tyrosine and catecholamines","volume":"42","author":"Smith","year":"1975","journal-title":"Psychopharmacologia"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/QAI.0000000000000954","article-title":"Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between HIV infected and uninfected people?","volume":"72","author":"So-Armah","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2019.146398_b2290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(94)90023-X","article-title":"Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat\u2013a pharmacokinetic microdialysis study","volume":"262","author":"Spanagel","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2295","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdv606","article-title":"Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group","volume":"27","author":"Spano","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.brainres.2019.146398_b2300","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pnpbp.2012.10.006","article-title":"Immune changes and neurotransmitters: possible interactions in depression?","volume":"48","author":"Sperner-Unterweger","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2013.04.018","article-title":"Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic review","volume":"150","author":"Spies","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b2310","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/09540120802657555","article-title":"Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy","volume":"21","author":"Springer","year":"2009","journal-title":"AIDS care"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2315","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/jir387","article-title":"Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden","volume":"204","author":"Spudich","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/COH.0000000000000243","article-title":"Immune activation in the central nervous system throughout the course of HIV infection","volume":"11","author":"Spudich","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.brainres.2019.146398_b2325","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI127413","article-title":"Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance","volume":"130","author":"Spudich","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2330","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0006-8993(86)90087-9","article-title":"Sub-second striatal dopamine release measured by in vivo voltammetry","volume":"381","author":"Stamford","year":"1986","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00497003","article-title":"Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro","volume":"305","author":"Starke","year":"1978","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b2340","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2345","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/acs.jmedchem.6b01827","article-title":"Triple reuptake inhibitors as potential therapeutics for depression and other disorders: design paradigm and developmental challenges","volume":"61","author":"Subbaiah","year":"2018","journal-title":"J. Med. Chem."},{"issue":"2\u20133","key":"10.1016\/j.brainres.2019.146398_b2350","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2011.01.014","article-title":"Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection","volume":"117","author":"Sullivan","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b2355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207055","article-title":"Gender disparities in depression severity and coping among people living with HIV\/AIDS in Kolkata, India","volume":"13","author":"Swendeman","year":"2018","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b2360","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1089\/aid.2012.0018","article-title":"Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy","volume":"28","author":"Szadkowski","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1570162X12666140526114956","article-title":"Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection","volume":"12","author":"Tavazzi","year":"2014","journal-title":"Curr. HIV Res."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b2370","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1016\/S2352-3018(17)30155-8","article-title":"New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004\u201315: an analysis of surveillance data","volume":"4","author":"Tavoschi","year":"2017","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2375","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0031-9384(95)02088-8","article-title":"Male reproductive systems under chronic fluoxetine or trimipramine treatment","volume":"59","author":"Taylor","year":"1996","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2019.146398_b2380","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1888","article-title":"Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies","volume":"348","author":"Taylor","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.brainres.2019.146398_b2385","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/641913","article-title":"HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities","volume":"2015","author":"Tedaldi","year":"2015","journal-title":"Biomed Res. Int."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2390","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hiv.12421","article-title":"Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis","volume":"18","author":"Teeraananchai","year":"2017","journal-title":"HIV Med."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b2395","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/501454","article-title":"Psychotropic medications and HIV","volume":"42","author":"Thompson","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2400","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s13365-018-0699-0","article-title":"Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life","volume":"25","author":"Tierney","year":"2019","journal-title":"J. Neurovirol."},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b2405","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1007\/s11064-017-2270-4","article-title":"Microglia Loss contributes to the development of major depression induced by different types of chronic stresses","volume":"42","author":"Tong","year":"2017","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/toxsci\/60.1.103","article-title":"Seizure activity and hyperthermia potentiate the increases in dopamine and serotonin extracellular levels in the amygdala during exposure to d-amphetamine","volume":"60","author":"Tor-Agbidye","year":"2001","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13318-018-0507-5","article-title":"Impact of efavirenz metabolism on loss to care in older HIV+ Africans","volume":"44","author":"Torgersen","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11904-013-0168-6","article-title":"Cardiovascular disease and HIV infection","volume":"10","author":"Triant","year":"2013","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"12","key":"10.1016\/j.brainres.2019.146398_b2425","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archgenpsychiatry.2010.160","article-title":"A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV","volume":"67","author":"Tsai","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"23","key":"10.1016\/j.brainres.2019.146398_b2430","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1523\/JNEUROSCI.1124-04.2004","article-title":"Catechol-<em>O<\/em>-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex","volume":"24","author":"Tunbridge","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146398_b2435","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11740","article-title":"Dopamine neurons modulate neural encoding and expression of depression-related behaviour","volume":"493","author":"Tye","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.146398_b2440","unstructured":"UNAIDS, 2013. HIV and aging: A special supplement to the UNAIDS report on the global AIDS epidemic 2013."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2445","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11904-016-0324-x","article-title":"Guidelines for evaluation and management of cognitive disorders in HIV-positive individuals","volume":"13","author":"Underwood","year":"2016","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2019.146398_b2450","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00002030-200418001-00012","article-title":"Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms","volume":"18","author":"Valcour","year":"2004","journal-title":"AIDS (London, England)"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2455","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","article-title":"Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort","volume":"63","author":"Valcour","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2460","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/13550280802216494","article-title":"Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy","volume":"14","author":"Valcour","year":"2008","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2465","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central nervous system viral invasion and inflammation during acute HIV infection","volume":"206","author":"Valcour","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b2470","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1128\/AAC.01243-06","article-title":"Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects","volume":"51","author":"van der Lee","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2475","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1176\/jnp.4.3.280","article-title":"Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia","volume":"4","author":"van Gorp","year":"1992","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2480","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jana.2010.04.002","article-title":"Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life","volume":"22","author":"Vance","year":"2011","journal-title":"J. Assoc. Nurses AIDS Care"},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b2485","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1111\/ejn.12709","article-title":"Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery","volume":"40","author":"Vander Weele","year":"2014","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2490","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13365-014-0258-2","article-title":"Glutamate metabolism and HIV-associated neurocognitive disorders","volume":"20","author":"V\u00e1zquez-Santiago","year":"2014","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ntt.2004.09.008","article-title":"Neurobehavioral effects of prenatal exposure to AZT: a preliminary investigation with the D1 receptor agonist SKF 38393 in mice","volume":"27","author":"Venerosi","year":"2005","journal-title":"Neurotoxicol. Teratol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2500","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1176\/ajp.155.2.200","article-title":"Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study","volume":"155","author":"Volkow","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2505","doi-asserted-by":"crossref","first-page":"p. RC121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","article-title":"Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"issue":"4007","key":"10.1016\/j.brainres.2019.146398_b2510","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.174.4007.408","article-title":"Dopamine: release from the brain in vivo by amantadine","volume":"174","author":"Von Vigtlander","year":"1971","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2515","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2520","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4088\/JCP.v61n0608","article-title":"Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial","volume":"61","author":"Wagner","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11126-007-9055-x","article-title":"Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression","volume":"79","author":"Walkup","year":"2008","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.brainres.2019.146398_b2530","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4690-11-35","article-title":"Rapid inflammasome activation in microglia contributes to brain disease in HIV\/AIDS","volume":"11","author":"Walsh","year":"2014","journal-title":"Retrovirology"},{"issue":"Pt 11","key":"10.1016\/j.brainres.2019.146398_b2535","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/brain\/awh269","article-title":"Decreased brain dopaminergic transporters in HIV-associated dementia patients","volume":"127","author":"Wang","year":"2004","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2540","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12974-018-1137-1","article-title":"Critical role of NLRP3-caspase-1 pathway in age-dependent isoflurane-induced microglial inflammatory response and cognitive impairment","volume":"15","author":"Wang","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2545","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12888-018-1741-8","article-title":"Prevalence of depression or depressive symptoms among people living with HIV\/AIDS in China: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"22","key":"10.1016\/j.brainres.2019.146398_b2550","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.1104836108","article-title":"Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans","volume":"108","author":"Warner-Schmidt","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b2555","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/11592070-000000000-00000","article-title":"Safety considerations in drug treatment of depression in HIV-positive patients","volume":"34","author":"Watkins","year":"2011","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2560","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13365-012-0108-z","article-title":"Neuropsychiatric complications of aging with HIV","volume":"18","author":"Watkins","year":"2012","journal-title":"J. Neurovirol."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b2565","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1212\/01.WNL.0000120622.91018.EA","article-title":"Symptomatic distal sensory polyneuropathy in HIV after age 50","volume":"62","author":"Watters","year":"2004","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b2570","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1523\/JNEUROSCI.16-10-03474.1996","article-title":"Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats","volume":"16","author":"Weiss","year":"1996","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2575","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1532-5415.2002.50152.x","article-title":"HIV infection: treatment outcomes in older and younger adults","volume":"50","author":"Wellons","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2580","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s13365-012-0094-1","article-title":"Impact of HIV and aging on neuropsychological function","volume":"18","author":"Wendelken","year":"2012","journal-title":"J. NeuroVirol."},{"key":"10.1016\/j.brainres.2019.146398_b2585","unstructured":"WHO, 2018. Ageing and health."},{"issue":"Pt C","key":"10.1016\/j.brainres.2019.146398_b2590","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers \u2013 a meta-analysis","volume":"80","author":"Wiedlocha","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.brainres.2019.146398_b2595","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1460-9568.2007.05772.x","article-title":"Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens","volume":"26","author":"Wightman","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2019.146398_b2600","doi-asserted-by":"crossref","DOI":"10.2174\/1570162X12666140526114526","article-title":"Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders","author":"Williams","year":"2014","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.brainres.2019.146398_b2605","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.neuro.25.112701.142822","article-title":"Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS","volume":"25","author":"Williams","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2610","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"Striatal dopamine nerve terminal markers in human, chronic methamphetamine users","volume":"2","author":"Wilson","year":"1996","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2615","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/npp.2014.327","article-title":"Measuring cigarette smoking-induced cortical dopamine release: A [11C]FLB-457 PET study","volume":"40","author":"Wing","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.146398_b2620","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","article-title":"HIV and aging","volume":"53","author":"Wing","year":"2016","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2625","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QCO.0000000000000117","article-title":"Emerging concepts on the use of antiretroviral therapy in older adults living with HIV infection","volume":"28","author":"Winston","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.brainres.2019.146398_b2630","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrn.2016.69","article-title":"Integrating neuroimmune systems in the neurobiology of depression","volume":"17","author":"Wohleb","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2635","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mp.2016.46","article-title":"Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition","volume":"21","author":"Wong","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.brainres.2019.146398_b2640","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/j.1326-5377.1989.tb136499.x","article-title":"Zidovudine-related mania","volume":"150","author":"Wright","year":"1989","journal-title":"Med. J. Aust."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2645","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11481-009-9174-2","article-title":"CNS inflammation and macrophage\/microglial biology associated with HIV-1 infection","volume":"4","author":"Yadav","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2650","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.1969.00480160015001","article-title":"Treatment of parkinsonism with levodopa","volume":"21","author":"Yahr","year":"1969","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2019.146398_b2655","doi-asserted-by":"crossref","first-page":"367","DOI":"10.12659\/MSM.895739","article-title":"Haloperidol suppresses NF-kappaB to inhibit lipopolysaccharide-induced pro-inflammatory response in RAW 264 cells","volume":"22","author":"Yamamoto","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0741-8329(99)00006-3","article-title":"Extracellular dopamine and serotonin after ethanol monitored with 5-minute microdialysis","volume":"19","author":"Yan","year":"1999","journal-title":"Alcohol"},{"issue":"1","key":"10.1016\/j.brainres.2019.146398_b2665","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2670","first-page":"61","article-title":"Choosing antidepressants for HIV and AIDS patients: insights on safety and side effects","volume":"5","author":"Yanofski","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"issue":"10","key":"10.1016\/j.brainres.2019.146398_b2675","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","article-title":"Depression as a microglial disease","volume":"38","author":"Yirmiya","year":"2015","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2680","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0893-133X(98)00082-7","article-title":"Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus","volume":"20","author":"Youngren","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2019.146398_b2685","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s13365-013-0150-5","article-title":"Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China","volume":"19","author":"Yuan","year":"2013","journal-title":"J. Neurovirol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2690","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.qai.0000147524.19122.fd","article-title":"Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients","volume":"38","author":"Yun","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2695","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbi.2009.11.004","article-title":"Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy","volume":"24","author":"Zangerle","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.brainres.2019.146398_b2700","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/apc.2006.0043","article-title":"Age difference in rates of mental health\/substance abuse and behavioral care in HIV-positive adults","volume":"21","author":"Zanjani","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.brainres.2019.146398_b2705","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.coi.2014.06.007","article-title":"Aging of the human innate immune system in HIV infection","volume":"29","author":"Zapata","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.brainres.2019.146398_b2710","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1532-5415.2010.03011.x","article-title":"The blood-brain barrier: geriatric relevance of a critical brain-body interface","volume":"58","author":"Zeevi","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2715","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0893-133X(00)00119-6","article-title":"Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex","volume":"23","author":"Zhang","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2019.146398_b2720","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/npp.2008.134","article-title":"Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice","volume":"34","author":"Zhang","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.brainres.2019.146398_b2725","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.7150\/jca.20850","article-title":"Potential roles of peripheral dopamine in tumor immunity","volume":"8","author":"Zhang","year":"2017","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2730","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1124\/mol.104.000299","article-title":"Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release","volume":"66","author":"Zhang","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b2735","article-title":"Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis","volume":"18","author":"Zhou","year":"2015","journal-title":"J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2740","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1124\/jpet.108.150144","article-title":"HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes","volume":"329","author":"Zhu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.brainres.2019.146398_b2745","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/syn.20949","article-title":"Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity","volume":"65","author":"Zhu","year":"2011","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.brainres.2019.146398_b2750","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s13365-015-0391-6","article-title":"HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum","volume":"22","author":"Zhu","year":"2016","journal-title":"J. Neurovirol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319304524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319304524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:04:40Z","timestamp":1757786680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319304524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":550,"alternative-id":["S0006899319304524"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146398","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146398"}}